18164554|t|Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
18164554|a|Acetylcholinesterase (AChE) is shown to promote deposition of beta-amyloid (Abeta) peptides and to enhance Abeta toxicity. Tg2576 (transgenic mice carrying the Swedish mutation of amyloid precursor protein, APPswe) mice and mice overexpressing human synaptic acetylcholinesterase (AChE-S) were crossed (hAChE-Tg//APPswe), to study the effects of brain Abeta, from 1 to 10 months of age, under the constant influence of AChE-S. The effect of nicotine treatment was also evaluated in these mice since we have previously shown that nicotine dramatically decreases Abeta levels in single transgenic APPswe mice. Already at 1 and 3 months, hAChE-Tg// APPswe mice showed increased levels of cortical insoluble Abeta1-40 and Abeta1-42 compared with APPswe mice, whereas APPswe mice displayed increased soluble Abeta1-40. Abeta plaques were detected at 7 months, thus before onset of plaque formation in APPswe mice. No differences were found in [125I]alpha-bungarotoxin binding sites or hippocampal glial fibrillary acidic protein (GFAP) immunoreactivity between hAChE-Tg//APPswe, and APPswe mice at either 1 or 10 months of age. L(-)-Nicotine (final dose 0.45 mg/kg) treatment twice daily for 10 days to 14-month-old hAChE-Tg// APPswe mice increased cortical insoluble Abeta1-40 levels, while both L(-)- and D(+)-nicotine (final dose 0.45 mg/kg) increased soluble Abeta1-42. L(-)-Nicotine reduced hippocampal GFAP immunoreactivity both in hAChE-Tg//APPswe mice and non-transgenic controls, while D(+)-nicotine caused a decrease only in hAChE-Tg//APPswe mice. Moreover, D(+)-nicotine increased the [125I]alpha-bungarotoxin binding sites in the hippocampus, and cortex of the hAChE-Tg//APPswe mice. In conclusion, already at a very young age, hAChE-Tg// APPswe mice exhibit increased levels of aggregated Abeta compared with APPswe mice, due to the possible interaction between Abeta and AChE-S, whereas APPswe mice exhibit increased soluble Abeta. The interaction between Abeta and AChE-S may also explain the different effect of nicotine on Abeta pathology in the hAChE-Tg//APPswe mice. The results in this study emphasize the importance of using different transgenic mouse models for evaluating the effect of new drug candidates for the treatment of Alzheimer's disease.
18164554	11	15	mice	Species	10090
18164554	31	36	human	Species	9606
18164554	37	57	acetylcholinesterase	Gene	43
18164554	74	99	amyloid precursor protein	Gene	11820
18164554	120	128	nicotine	Chemical	MESH:D009538
18164554	140	160	Acetylcholinesterase	Gene	43
18164554	162	166	AChE	Gene	11423
18164554	216	221	Abeta	Gene	11820
18164554	247	252	Abeta	Gene	11820
18164554	253	261	toxicity	Disease	MESH:D064420
18164554	282	286	mice	Species	10090
18164554	320	345	amyloid precursor protein	Gene	11820
18164554	347	353	APPswe	CellLine	CVCL:D650
18164554	355	359	mice	Species	10090
18164554	364	368	mice	Species	10090
18164554	384	389	human	Species	9606
18164554	399	419	acetylcholinesterase	Gene	43
18164554	421	427	AChE-S	Gene	43
18164554	492	497	Abeta	Gene	11820
18164554	559	565	AChE-S	Gene	43
18164554	581	589	nicotine	Chemical	MESH:D009538
18164554	628	632	mice	Species	10090
18164554	669	677	nicotine	Chemical	MESH:D009538
18164554	701	706	Abeta	Gene	11820
18164554	735	741	APPswe	CellLine	CVCL:D650
18164554	742	746	mice	Species	10090
18164554	793	797	mice	Species	10090
18164554	889	893	mice	Species	10090
18164554	910	914	mice	Species	10090
18164554	954	959	Abeta	Gene	11820
18164554	1043	1047	mice	Species	10090
18164554	1079	1102	125I]alpha-bungarotoxin	Chemical	-
18164554	1132	1163	glial fibrillary acidic protein	Gene	14580
18164554	1165	1169	GFAP	Gene	14580
18164554	1225	1229	mice	Species	10090
18164554	1268	1276	Nicotine	Chemical	MESH:D009538
18164554	1369	1373	mice	Species	10090
18164554	1432	1437	L(-)-	Chemical	MESH:D007930
18164554	1442	1455	D(+)-nicotine	Chemical	MESH:C014173
18164554	1514	1522	Nicotine	Chemical	MESH:D009538
18164554	1543	1547	GFAP	Gene	14580
18164554	1590	1594	mice	Species	10090
18164554	1630	1643	D(+)-nicotine	Chemical	MESH:C014173
18164554	1687	1691	mice	Species	10090
18164554	1703	1716	D(+)-nicotine	Chemical	MESH:C014173
18164554	1732	1755	125I]alpha-bungarotoxin	Chemical	-
18164554	1825	1829	mice	Species	10090
18164554	1893	1897	mice	Species	10090
18164554	1937	1942	Abeta	Gene	11820
18164554	1964	1968	mice	Species	10090
18164554	2010	2015	Abeta	Gene	11820
18164554	2036	2042	APPswe	CellLine	CVCL:D650
18164554	2043	2047	mice	Species	10090
18164554	2074	2079	Abeta	Gene	11820
18164554	2105	2110	Abeta	Gene	11820
18164554	2163	2171	nicotine	Chemical	MESH:D009538
18164554	2175	2180	Abeta	Gene	11820
18164554	2215	2219	mice	Species	10090
18164554	2302	2307	mouse	Species	10090
18164554	2385	2404	Alzheimer's disease	Disease	MESH:D000544
18164554	Positive_Correlation	11820	43
18164554	Association	MESH:D064420	43
18164554	Association	MESH:D000544	43
18164554	Negative_Correlation	MESH:D009538	14580
18164554	Association	MESH:D064420	11423
18164554	Positive_Correlation	MESH:C014173	11820
18164554	Positive_Correlation	11423	11820
18164554	Negative_Correlation	MESH:D009538	11820

